Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)

Bibliographic Details
Title:	Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)
Authors:	Drake, Marcus J., Chapple, Christopher, Esen, Ahmet A., Athanasiou, Stavros, Cambronero, Javier, Mitcheson, David, Herschorn, Sender, Saleem, Tahir, Huang, Moses, Siddiqui, Emad, Stölzel, Matthias, Herholdt, Claire, MacDiarmid, Scott
Source:	European urology. 70(1):136-145
Availability:	http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100066187395.0x000001&indx=1&recIds=ETOCvdc_100066187395.0x000001
Database:	British Library Document Supply Centre Inside Serials & Conference Proceedings